Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

256

Participants

Timeline

Start Date

June 21, 2017

Primary Completion Date

September 29, 2020

Study Completion Date

September 29, 2020

Conditions
Tardive Dyskinesia
Interventions
DRUG

MT-5199

MT-5199 40 mg capsules

DRUG

Placebo

MT-5199 placebo capsules

Trial Locations (82)

Unknown

Aichi Psychiatric Medical Center, Aichi

Hotei Hospital, Aichi

Mikawa Hospital, Aichi

Okehazama Hospital Fujita Kokoro Care Center, Aichi

Akita City Hospital, Akita

Akita University Hospital, Akita

Hirosaki Aiseikai Hospital, Aomori

Minato Hospital, Aomori

Seinan Hospital, Aomori

Kohnodai Hospital , National Center for Global Health and Medicine, Chiba

National Hospital Organization Shimofusa Psychiatric Medical Center, Chiba

General incorporated association Shinkoukai Shinkouen, Ehime

Chikusuikai Hospital, Fukuoka

Fukuoka University Hospital, Fukuoka

Hirota Clinic, Fukuoka

Iizukakinen Hospital, Fukuoka

Kuramitsu Hospital, Fukuoka

Minamigaoka Hospital, Fukuoka

Yahata Kousei Hospital, Fukuoka

Nanko Kokorono Clinic, Fukushima

Takeda General Hospital, Fukushima

Holy Cross Hospital, Gifu

Seimou Hospital, Gunma

Hayakawa Clinic, Hiroshima

Kamo Psychiatric Center, Hiroshima

Medical corporation KOSEIKAI KUSATSU HOSPITAL, Hiroshima

Mihara Hospital, Hiroshima

Hayashishita Hospital, Hokkaido

Ishikane Hospital, Hokkaido

National Hospital Organization Hokkaido Medical Center, Hokkaido

Obihiro-Kosei General Hospital, Hokkaido

Sapporo City General Hospital, Hokkaido

Teine Hospital, Hokkaido

Hyogo prefecture - Hyogo Mental Health Center, Hyōgo

Kobe University Hospital, Hyōgo

Medical corporation Shouhokai Toda Internal Medicine and Rehabilitation Department, Hyōgo

Awazu Neuropsychiatric Sanatorium, Ishikawa

Ishiki Hospital, Kagoshima

Minami Kyushu Sakura Hospital, Kagoshima

Taniyama Hospital, Kagoshima

Fujimidai Hospital, Kanagawa

Hatano Kosei Hospital, Kanagawa

Hino Hospital, Kanagawa

Kishiro Mental Clinic, Kanagawa

Kitaodawara Hospital Meihoukai Medical Corporation Association, Kanagawa

Shiunkai Yokohama Hospital, Kanagawa

Soushu Hospital, Kanagawa

Yatsushirokosei Hospital, Kumamoto

Yuge Hospital, Kumamoto

Sagaarashiyama Tanaka Clinic, Kyoto

Miyagi Psychiatric Center, Miyagi

Yasuda Hospital, Miyagi

National Hospital Organization Komoro kogen Hospital, Nagano

North Alps Medical Center Azumi Hospital, Nagano

Syonan Hospital, Nagano

Sanwa Central Hospital, Nagasaki

Nara Medical University Hospital, Nara

Akari Clinic, Okinawa

Arakaki Hospital, Okinawa

Samariya Hospital, Okinawa

Keihan Hospital, Osaka

Kyowakai Healthcare Corpration Hannan Hospital, Osaka

Hoaki Hospital, Ōita

Hizen Psychiatric Center, Saga

Rainbow & Sea Hospital, Saga

Sho Midori Hospital, Saitama

Shiga University of Medical Science Hospital, Shiga

Shimane University Hospital, Shimane

Numazu Chuo Hospital, Shizuoka

Abe Clinic, Tokyo

Hozumi Clinic, Tokyo

Kyorin University Hospital, Tokyo

Maynds Tower Mental Clinic, Tokyo

National Center of Neurology and Psychiatry, Tokyo

Nishigahara Hospital, Tokyo

Ongata Hospital, Tokyo

Sangenjaya Neurology-Psychosomatic Clinic, Tokyo

Senzoku Mental Clinic, Tokyo

Kawada Hospital, Toyama

Minamitoyama Nakagawa Hospital, Toyama

Public Okitama General Hospital, Yamagata

National Hospital Organization Kanmon Medical Center, Yamaguchi

All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY